A Study of Mirikizumab (LY3074828) Injection in Healthy Participants
Clinical trial NCT03053622 · COMPLETED
Trial details
- NCT number
- NCT03053622
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2018-04-03
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.